Additional Roundup Expert Testimony to Be Considered by MDL Judge

The U.S. District Judge presiding over all federal Roundup lawsuits has scheduled additional hearings to consider further testimony from two expert witnesses regarding the risk of non-Hodgkins lymphoma from exposure to the widely used weedkiller.

There are currently about 380 product liability lawsuits pending against Monsanto in the federal court system, each raising similar claims that inadequate warnings were provided for farmers, landscapers and other consumers about the cancer risks associated with exposure to Roundup and the herbicide’s active ingredient, glyphosate.

Given similar questions of fact and law raised in the Roundup litigation, the federal claims are all centralized before U.S. District Judge Vince Chhabria for coordinated discovery and pretrial proceedings in the Northern District of California.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More See If You Qualify For Compensation

As part of the coordinated management, Judge Chhabri previously bifurcated the proceedings, indicating that the Court will first address the general causation link between Roundup and cancer, before considering any case-specific issues about whether the weedkiller caused any individual plaintiff’s diagnosis.

Last week, Judge Chhabri heard several days of testimony as part of Daubert hearings conducted to weigh the admissibility of expert witness testimony proposed by each side.

However, in pretrial order (PDF) issued on March 19, Judge Chharbi scheduled a telephone case management conference to discuss the scheduling of additional hearings to address epidemiological evidence offered by one experts, and to ask follow up questions to another expert. According to a docket notice posted today, those hearings are scheduled for April 4 and April 6.

After weighing the evidence on the link between Roundup and cancer, Judge Chhabri is expected to rule on whether certain opinions are sufficiently reliable and based on sound science to allow juries to consider the testimony at trial.

If the experts are not excluded or a Roundup settlement is not reached to resolve the litigation, it is expected that Judge Chhabri will schedule a series of early “bellwether” trials, where small groups of representative cases will be prepared for individual trial dates to allow the parties to gauge how juries may respond to certain evidence that is likely to be repeated throughout the proceedings.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.